09/22/2020 12:00 AM EDT
Source: World Health Organization (WHO). Published: 9/22/2020. This 72-page document from the Global Antimicrobial Resistance and Use Surveillance System (GLASS) addresses the applications of whole-genome sequencing (WGS) for antimicrobial resistance (AMR) surveillance, including the benefits and limitations of current WGS technologies. Local, subnational, national and international case studies are included as examples of use of WGS in AMR surveillance. (PDF)
09/22/2020 12:00 AM EDT
Source: Centers for Disease Control and Prevention, Office of Infectious Diseases (CDC OID). Published: 9/22/2020. This web page recommends checking for hazards before reopening a building after a prolonged period of building inactivity, and provides guidance about mold, Legionella and Legionnaires’ disease, and lead and copper. (Text)
09/21/2020 12:00 AM EDT
Source: U.S. Government Accountability Office (GAO). Published: 9/21/2020. This 371-page report updates the GAO's oversight of federal actions to support public health, individuals, and the economy during the COVID-19 pandemic, and details evolving lessons learned relevant to the nation’s response to pandemics. It provides 16 recommendations for federal agencies. (PDF)
09/21/2020 12:00 AM EDT
Source: Centers for Disease Control and Prevention, Office of Infectious Diseases (CDC OID). Published: 9/21/2020. This workflow and additional information are intended to be professionally generated as a job aid for distribution via CDC country offices to local Ministries of Health or National Public Health Institutes with the intent to be given to facilities with frontline healthcare workers doing COVID-19 contact tracing, case investigations, community outreach, or in other ways working with potential contacts. (Text)
09/18/2020 12:00 AM EDT
Source: Centers for Disease Control and Prevention, Office of Infectious Diseases (CDC OID). Published: 9/18/2020. This web page, updated on September 18, 2020, provides answers to frequently asked questions about contact tracing, with topics covering basics, and digital tools and information. It also provides links to additional resources. (Text)
09/18/2020 12:00 AM EDT
Source: U.S. Food and Drug Administration (FDA). Published: 9/18/2020. This three-page fact sheet informs healthcare providers of the significant known and potential risks and benefits of the emergency use of the GK ACCU-RIGHT SARS-CoV-2 RT-PCR KIT. The GK ACCU-RIGHT SARS-CoV-2 RT-PCR KIT is authorized for use with upper respiratory specimens collected from individuals suspected of COVID-19 by their healthcare provider. (PDF)
09/18/2020 12:00 AM EDT
Source: Centers for Disease Control and Prevention, Office of Infectious Diseases (CDC OID). Published: 9/18/2020. This resource provides example evaluation questions, indicators, and data sources to help state and local public health and education agencies, school and district administrators, and evaluation professionals monitor and evaluate the implementation and impact of COVID-19 mitigation strategies implemented in K-12 schools on the transmission of SARS-CoV-2, the virus that causes COVID-19. (Text)
09/03/2020 12:00 AM EDT
Source: Centers for Disease Control and Prevention, Office of Infectious Diseases (CDC OID). Published: 9/3/2020. This web page, updated on September 3, 2020, provides information about the CDC Influenza SARS-CoV-2 (Flu SC2) Multiplex Assay, which is a real-time reverse-transcriptase polymerase chain reaction (RT-PCR) test that detects and differentiates RNA from SARS-CoV-2, influenza A virus, and influenza B virus in upper or lower respiratory specimens. The Food and Drug Administration (FDA) granted an Emergency Use Authorization (EUA) for this test on July 2, 2020. Test kits are in production and will be shipped to public health laboratories once production, including quality control and assembly, has been completed. (Text)
09/03/2020 12:00 AM EDT
Source: Centers for Disease Control and Prevention, Office of Infectious Diseases (CDC OID). Published: 9/3/2020. The trainings listed on this web page are for public health professionals or the general public who are interested in becoming a contact tracer or case investigator, as well as for public health professionals who already serve in these roles and are seeking to improve their knowledge. (Video or Multimedia)
09/01/2020 12:00 AM EDT
Source: World Health Organization, Regional Office for the Eastern Mediterranean. Published: 9/2020. This 68-page report summarizes a six-month review of the Incident Management Support Team (IMST) response to the COVID-19 pandemic in the Eastern Mediterranean Region. A theme running throughout is the IMST’s role in coordination of the COVID-19 response, particularly in bringing together regional partners and driving forward the operational response. (PDF)
08/01/2020 12:00 AM EDT
Source: World Health Organization, Regional Office for Africa. Published: 8/2020. This 27-page monitoring and evaluation framework targets ministries of health, WHO country offices, and the Regional Office, and aims to assess national, country, and regional response performance and progress, measured against country national plans, response efforts, and the broader WHO COVID-19 Strategic Preparedness and Response Plan. (PDF)
.png)
No hay comentarios:
Publicar un comentario